Practical Assessment of Psoriasis Clinical Severity in both Clinical Trials and Clinical Practice Settings: A Report from the GRAPPA 2016 Annual Meeting

被引：2

作者：

Merola, Joseph F. ^{[1
]}

Gottlieb, Alice B. ^{[2
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol, Dept Dermatol & Med, 75 Francis St, Boston, MA 02115 USA

[2] New York Med Coll, Dermatol, Valhalla, NY 10595 USA

来源：

JOURNAL OF RHEUMATOLOGY | 2017年 / 44卷 / 05期

关键词：

PSORIATIC ARTHRITIS; PSORIASIS; COMBINED CLINIC; GRAPPA; EFFICACY; MODERATE; AREA;

D O I：

10.3899/jrheum.170147

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

At the 2016 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), we presented the case for quantitatively assessing the extent of both psoriasis and psoriatic arthritis in the clinical setting, with a particular focus on the validation and expanded novel use of the PGAxBSA (static physician's global assessment x body surface area of involvement) in the era of targeted metrics. Herein, we summarize our presentation.

引用

页码：691 / 692

页数：2

共 50 条

[31] Psoriasis: talking points from recent clinical trials
Chiricozzi, Andrea
Bellinato, Francesco
Romita, Paolo
Gisondi, Paolo
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (12) : 1265 - 1267
[32] Outcomes in Psoriasis Clinical Trials from January 2011 to March 2012
Francesca Sampogna
Damiano Abeni
Current Dermatology Reports, 2012, 1 (3): : 137 - 147
[33] Outcomes in Psoriasis Clinical Trials from January 2011 to March 2012
Sampogna, Francesca
Abeni, Damiano
CURRENT DERMATOLOGY REPORTS, 2012, 1 (03) : 137 - 147
[34] Rufinamide from clinical trials to clinical practice in the United States and Europe
Resnick, Trevor
Arzimanoglou, Alexis
Brown, Lawrence W.
Flamini, Robert
Kerr, Michael
Kluger, Gerhard
Kothare, Sanjeev
Philip, Sunny
Harrison, Miranda
Narurkar, Milind
EPILEPTIC DISORDERS, 2011, 13 : S27 - S43
[35] Therapies in ankylosing spondylitis-from clinical trials to clinical practice
Tahir, Hasan
RHEUMATOLOGY, 2018, 57 : 23 - 28
[36] Facial Psoriasis Log-based Area and Severity Index: A valid and reliable severity measurement method detecting improvement of facial psoriasis in clinical practice settings
Kwon, Hyuck Hoon
Kim, Min-Woo
Park, Gyeong-Hun
Bae, You In
Kuk, Su Kyung
Suh, Dae Hun
Youn, Jai Il
Kwon, In Ho
JOURNAL OF DERMATOLOGY, 2016, 43 (08) : 894 - 899
[37] Effect of statins on psoriasis severity: A meta-analysis of randomized clinical trials
Lopez, Abreu
Martinez, Ernesto Calderon
Cruz, Camila Sanchez
Xiao, Tania Siu
Carcamo, Zulma D. Sosa
Reyes, Alejandra M. Aleman
Bonilla, Felix R. Bonilla
Pineda, Maria I. Murillo
Herrera, Edgar J. Sanabria
Aguilar, Alberto J. Ayala
Marron, Andreina del Valle Rojas
Duran, Valentina Contreras
Romero, Kevin J. Lopez
Garzon, Marcela
RHEUMATOLOGY & AUTOIMMUNITY, 2025,
[38] The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials
Socha, Mateusz
Pietrzak, Aldona
Grywalska, Ewelina
Pietrzak, Daniel
Matosiuk, Dariusz
Kicinski, Pawel
Rolinski, Jacek
ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (01) : 1 - 7
[39] Using Hawthorne Effects to Improve Adherence in Clinical Practice: Lessons From Clinical Trials Reply
Gelfand, Joel M.
Wang, Shuwei
Takeshita, Junko
Robertson, Andrew D.
Krueger, Gerald G.
Duffin, Kristina Callis
Van Voorhees, Abby S.
JAMA DERMATOLOGY, 2013, 149 (04) : 491 - 491
[40] Correlation Between Change in Psoriasis Area and Severity Index and Dermatology Life Quality Index in Patients with Psoriasis: Pooled Analysis from Four Phase 3 Clinical Trials of Secukinumab
Houghton, Katherine
Patil, Dhaval
Gomez, Braulio
Feldman, Steven R.
DERMATOLOGY AND THERAPY, 2021, 11 (04) : 1373 - 1384

← 1 2 3 4 5 →